经皮胆管腔内射频消融治疗恶性胆管梗阻中国专家共识(2022年版)  

Chinese expert consensus on clinical application of endobiliary radiofrequency ablation therapy for malignant biliary obstruction

作　　者：中国抗癌协会微创治疗专业委员会 李家平[2] The Professional Committee of Minimally Invasive Therapy of China Anti-Cancer Association;Li Jiaping(不详;Department of Interventional Radiology,the First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China)

机构地区：[1]不详 [2]中山大学附属第一医院肿瘤介入科,广州510080

出　　处：《中华内科杂志》2022年第5期488-495,共8页Chinese Journal of Internal Medicine

摘　　要：胆管腔内射频消融(endobiliary radiofrequency ablation,EB-RFA)是一种治疗恶性胆管梗阻(malignant biliary obstruction,MBO)的新方法,可作为姑息性治疗手段应用于胆管癌、胰头癌、转移性淋巴结等多种原因引起的MBO。因其具有微创及可重复进行等优点,在MBO初治中联合支架植入或支架植入后狭窄/阻塞支架再通中具有重要作用。在中国抗癌协会微创治疗专业委员会牵头下,组织该领域知名的专家,在参考国内外文献、结合临床经验与体会的基础上,针对EB-RFA治疗MBO的适应证、禁忌证、操作流程、并发症的处理以及疗效评价标准等问题达成统一意见,制定本共识,以期指导国内同行更好地应用EB-RFA治疗MBO。Endobiliary radiofrequency ablation(EB-RFA)is a novel therapy for malignant biliary obstruction(MBO),which is considered as a palliative treatment for MBO caused by cholangiocarcinoma,pancreatic head carcinoma,metastatic lymphadenopathy and other causes.Due to the advantages of minimal invasiveness and repeatability,EB-RFA plays an important role in the combination of stent implantation in the initial treatment of MBO or in the recanalization of stent stenosis/obstruction.In this expert consensus,the indications,contraindications,operation protocol and evaluation criteria of efficacy of EB-RFA were sufficiently discussed,which was organized by the Professional Committee of Minimally Invasive Therapy of China Anti-cancer Association.

关 键 词：胆道 黄疸 阻塞性 射频消融 放射学 介入性 

分 类 号：R735[医药卫生—肿瘤]